Monday March 30, 2026
Momentum is building around where care happens and how it scales — with robotics expanding their footprint, therapies moving into the home, and infrastructure racing to keep up.
8 things to watch this week:
1. 🤖 Medtronic pushes robotics into cranial & ENT procedures
Medtronic’s latest FDA clearance expands its robotic platform into cranial and ENT surgeries, signaling a continued push toward multi-specialty dominance. The bigger story: robotics is shifting from single-use cases to scalable surgical ecosystems.
MedTech Dive
2. 🎯 Before Your Commercial Story Gets Tested — Test It Yourself.
Most teams don’t pressure-test their commercial story ahead of time. They only find out where it breaks when it actually matters — in front of an investor, a health system, or a potential partner.
The CLIF Analysis was built for exactly this. Before the room. Before it matters.
RŌG Health is opening ten seats to a limited cohort for medtech and medical device companies at serious commercial inflection points. Two rounds of external analysis. Half the standard rate. Ten seats. First come, first served.
Learn more and register today →
Sponsored
3. 🧠 At-home neuromodulation gains traction post-FDA approval
With new funding following FDA approval, Neurolief is pushing neuromodulation into the home — a meaningful step toward decentralizing mental health treatment. This reinforces a broader shift: high-acuity therapies moving outside traditional care settings.
BioSpace
4. 💧 Boston Scientific secures FDA clearance for fluid management system
Boston Scientific’s new system targets improved visualization and pressure control during ureteroscopy procedures. While incremental, it reflects continued investment in procedural efficiency and outcomes in high-volume specialties.
Boston Scientific
5. 🧬 BioLargo subsidiary Clyra Medical accelerates toward product launches
Clyra Medical is moving closer to commercialization with its wound care platform, highlighting continued momentum in infection control and advanced healing technologies. The broader signal: niche clinical categories are becoming serious growth markets.
Seeking Alpha
🧠 Butterfly Network wins FDA clearance for AI-powered ultrasound tool
Butterfly’s newly cleared AI ultrasound can estimate gestational age in minutes without specialist interpretation, dramatically expanding access to prenatal imaging. The bigger signal: AI is starting to compress both expertise and infrastructure requirements in frontline care.
Reuters
7. 💻 VITL raises $7.5M to scale healthcare software platform
VITL’s Series A highlights ongoing investor appetite for infrastructure-layer healthcare software. The focus is clear: enabling interoperability and data flow across fragmented systems.
N24
❤️ JenaValve wins FDA approval for first-in-class aortic regurgitation valve
JenaValve’s FDA approval marks the first transcatheter device specifically designed for aortic regurgitation — a historically underserved condition. Beyond the clinical milestone, it signals renewed momentum in structural heart innovation following increased regulatory and antitrust scrutiny.
MedTech Dive
Want to put your brand in front of 35,000+ medical device and med tech leaders each week? Contact us to learn more about sponsorship opportunities.
🧭 About The Pathway
The Pathway is a curated briefing for medical device leaders, focused on regulatory moves, product launches, partnerships, and market signals shaping the industry.
If this was useful, consider subscribing or sharing with a colleague who should be tracking these developments.
Some issues may include sponsored or partner content. Sponsorship does not influence editorial selection of third-party news items.